Improving Retreatment Success (IMPRESS)

NCT02114684 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

197

Enrollment

NETWORK

Sponsor class

Conditions

Recurrent Tuberculosis

Interventions

DRUG: moxifloxacin

Sponsor

Centre for the AIDS Programme of Research in South Africa